Skip to main content

Post-IPO Equity Pharmaceutical Companies

Explore 204 pharmaceutical startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
204
Total Funding
$2.7B
Avg Funding
$108.0M
Cities
20

Export 204 Post-IPO Equity Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
New York, United States
$235.5M
raised

Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Markham, Canada
$5.0M
raised

1CM vision is to be the leading cannabis company globally with solutions that add value to consumers and companies.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$50.0M
raised

Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$5.0M
raised

Cyclerion Therapeutics harnesses the potential of soluble guanylate cyclase (sGC) pharmacology.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Seattle, United States
$67.8M
raised

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Diego, United States
$55.0M
raised

Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boca Raton, United States
$900K
raised

Smart for Life markets and manufactures nutritional foods and supplements for the global nutraceutical marketplace.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Perth, Australia
$2.5M
raised

Emria is a data-backed drug development and care delivery company.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Hamilton, Canada
$60.0M
raised

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Red Bank, United States
$35.0M
raised

Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing, and commercializing novel therapeutics.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New York, United States
$230.0M
raised

Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Carlos, United States
$2.8M
raised

Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.

Jan 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$287.5M
raised

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

Jan 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Houston, United States
$8.0M
raised

Kiromic develops biomarker- and small molecule-based diagnostic and therapeutic programs for solid tumors and hematologic malignancies.

Oct 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$34.2M
raised

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

Oct 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Vancouver, Canada
$100K
raised

Sproutly is the supplier of unique ingredients and customized formulations to the cannabis beverage and edibles market.

Sep 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cincinnati, United States
$225.0M
raised

CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.

Aug 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Macclesfield, United Kingdom
$43.6M
raised

Redx Pharma is a drug discovery and development company.

May 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Newton, United States
$2.8M
raised

Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.

May 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Corona, United States
$3.0M
raised

Ikänik Farms is engaged in cultivation, manufacturing, retail, and global distribution of cannabis and hemp CBD.

Apr 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
South San Francisco, United States
$10.0M
raised

Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.

Mar 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$3.1M
raised

Kanabo is creating a new standard in the medical cannabis industry by building an ecosystem.

Feb 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Las Vegas, United States
$7.9M
raised

Australis Capital is a pharmaceutical public company that develops and helps grow the cannabis industry to meet the growing market demand.

Feb 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$1.2B
raised

EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.

Dec 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$125.0M
raised

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

Dec 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 176 to 200 of 204 companies

Ready to Connect with Post-IPO Equity Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 204 post-ipo equity pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

204 Pharmaceutical Post-IPO Equity Startups (November 2026) — Page 8 | VCBacked